Webinar | February 5, 2021

Assess Pyrogenic Risk In Pharmaceutical Process With The Monocyte Activation Test

Microbial risk in pharmaceutical process cannot be limited to viable microorganisms. Learn how the MAT can help you to assess the pyrogenic risk resulting from your production process.

The monocyte activation test (MAT) provides an in vitro alternative to conventional animal testing methods in accordance with regulatory guidelines.

Speakers: Mathilde Arnault, Research Scientist, Merck KGaA, Darmstadt, Germany

access the Webinar!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

MilliporeSigma